Feeding Behaviors in Infants With Prenatal Opioid Exposure: An Integrative Review

Kelly McGlothen-Bell1, Lisa Cleveland, Pamela Recto

  • 1Office of Faculty Excellence, UT Health San Antonio, School of Nursing, San Antonio, Texas.

Insights

Feeding behaviors in infants with prenatal opioid exposure (POE) show inconsistencies. This review synthesizes evidence on typical and problematic feeding behaviors in POE infants, highlighting differences in sucking and state regulation.

Area of Science:

  • Neonatal development
  • Infant feeding
  • Developmental pediatrics

Background:

  • Oral feeding is a complex infant maturational skill.
  • Feeding difficulties can prolong hospital stays, especially for infants with prenatal opioid exposure (POE).
  • Limited research exists on the feeding behaviors of POE infants, despite common feeding problems.

Purpose of the Study:

  • To synthesize and critically analyze existing evidence on feeding behaviors in full-term infants with prenatal opioid exposure.
  • To characterize typical and problematic feeding behaviors in this population.

Main Methods:

  • An integrative review of studies from 1970-2019 was conducted.
  • Databases searched included CINAHL, PubMed, Scopus, and PsycINFO.
  • Four studies met inclusion criteria for full-term POE infants (38-40 weeks gestation).

Main Results:

  • Inconsistent characterization of feeding behaviors was found among POE infants.
  • Evidence-based infant feeding behaviors were synthesized.
  • Behaviors were categorized into typical and problematic domains.

Conclusions:

  • Feeding behaviors, particularly sucking and behavioral states, may differ in POE infants.
  • Further research is needed on effective assessment methods.
  • Development of evidence-based, targeted interventions for POE infant feeding is warranted.
Abstract

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.5K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
762
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
654
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
504